Ribociclib belongs to a class of medications called kinase inhibitors; it inhibits the cyclin-dependent kinase (CDK) 4 and 6. It is used for treating hormone receptor (HR)-positive, human ...

At the European Society for Medical Oncology (ESMO) Congress this week, investigators presented data for a new and potentially important drug, ribociclib (Novartis). This oral medication is ...

Ribociclib – a drug already used to treat breast cancer – may help slow ... tumours are more responsive to CDK4/CDK6 inhibitors than other high-grade glioma types – opening the door for more targeted ...

The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only improved invasive-free survival in women with this type of early-stage ...

Which type 2 diabetes treatment is right for you? If lifestyle changes alone don’t allow you to meet your blood sugar and A1C goals, your doctor may prescribe medication. Here are some factors ...

Luminal B is a specific type of breast cancer ... therapy with a combination of ribociclib and letrozole could be an alternative to multi-drug neoadjuvant chemotherapy. The trial involved high ...

Researchers used drugs Palbociclib and Ribociclib, which are known to block the CDK6 protein in multiplying cancer cells and found that it stopped the abnormal cell growth in animal models with ...

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding ... is taken with an aromatase inhibitor, a type of anti-cancer drug which blocks the production of the hormone ...

Penelope Oliver, a volunteer with Students Demand Action in California, talks to Hal about state laws involving firearms.

“We look forward to presenting updated data from our ongoing Phase 2 clinical study of palazestrant in combination with ribociclib in frontline metastatic ... application for OP-3136 to the U.S. Food ...

The US Food and Drug Administration (FDA) has approved Kisqali for early stage breast treatment. Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help ...

She focused on 2 FDA-approved antibody drug conjugates (ADCs): trastuzumab ... Previously, we could only use abemaciclib, and now we have a new ribociclib. If a patient is unable to tolerate ...